期刊文献+

益气化痰祛瘀方对慢性阻塞性肺疾病B组稳定期患者综合评估的影响 被引量:2

Effects of Yiqi Huatan Quyu Formula on comprehensive evaluation of patients with chronic obstructive pulmonary disease group B in stable period
原文传递
导出
摘要 目的:观察益气化痰祛瘀方对肺肾气虚、痰瘀阻肺证慢性阻塞性肺疾病(COPD)B组稳定期患者综合评估的影响。方法:将60例B组稳定期COPD患者随机分成治疗组和对照组,各30例,对照组给予噻托溴铵粉吸入剂,治疗组在对照组治疗基础上加用益气化痰祛瘀方,均治疗3个月,随访12个月,动态观察两组患者中医证候评分、肺功能(FEV_(1)、FVC)、呼吸困难分级量表(mMRC)评分、6分钟步行距离、急性加重次数以及生活质量评估(CAT评分)变化等。结果:治疗组治疗3个月及随访6、12个月中医证候评分、FEV_(1)、mMRC评分、6分钟步行距离、CAT评分均较对照组显著改善(P<0.05),两组时间效应、交互效应均显著(P<0.05);两组FVC值变化不明显。在急性加重次数上,治疗组显著少于对照组(P<0.05)。结论:益气化痰祛瘀方联合噻托溴铵粉吸入剂能改善COPD B组稳定期患者临床症状,提高运动耐力,维持肺功能稳定,减少急性加重次数,提高疗效。 Objective:To observe the effects of Yiqi Huatan Quyu Formula on comprehensive evaluation of patients with pulmonary kidney qi deficiency and phlegm-stasis obstructing lung syndrome chronic obstructive pulmonary disease(COPD)group B in stable period.Methods:Sixty patients with COPD group B in stable period were randomly divided into treatment group(30 cases)and the control group(30 cases);the control group was given Tiotropium,and in the treatment group,on the basis of the treatment in the control group,Yiqi Huatan Quyu Formula was added,two groups were treated for 3 months and followed up for 12 months,dynamic observation was made on the changes of TCM syndrome score,pulmonary function(FEV_(1),FVC),dyspnea rating scale(mMRC score),six-minute walking distance,acute exacerbation times and quality of life(CAT score),and the differences were compared.Results:Compared with the control group,TCM syndrome score,FEV_(1),mMRC score,six-minute walking distance and CAT score after treatment of 3 months and follow up for 6 months and 12 months in the treatment group were improved significantly(P<0.05),the time effects and interaction effects were significant in both groups(P<0.05),the two groups of FVC values do not change significantly.In the acute exacerbation times,the treatment group was significantly less than the control group(P<0.05).Conclusion:Yiqi Huatan Quyu Formula combined with Tiotropium can effectively improve clinical symptoms,improve exercise endurance,maintain lung function stability,and reduce the number of acute aggravation,to improve the efficacy.
作者 杨晓明 刘忠达 李泽庚 李权 刘笑静 周敏华 YANG Xiao-ming;LIU Zhong-da;LI Ze-geng;LI Quan;LIU Xiao-jing;ZHOU Min-hua(Pulmonary Department,Lishui Hospital of Traditional Chinese Medicine,Affliated to Zhejiang Chinese Medical University,Lishui 323000,China;Institute of Respiratory Disease,Anhui Academy of Chinese Medicine,Hefei 230038,China)
出处 《中华中医药杂志》 CAS CSCD 北大核心 2022年第11期6842-6846,共5页 China Journal of Traditional Chinese Medicine and Pharmacy
基金 国家中医药管理局慢性阻塞性肺疾病肺气虚证重点研究室开放基金项目(No.2014mzfyjs002) 丽水市中西医结合肺病学研究重点科技创新团队(No.2018cxtd08)。
关键词 益气化痰祛瘀方 慢性阻塞性肺疾病 稳定期 肺肾气虚、痰瘀阻肺证 综合评估 重复方差分析 Yiqi Huatan Quyu Formula Chronic obstructive pulmonary disease(COPD) Stable period Pulmonary kidney qi deficiency and phlegm-stasis obstructing lung syndrome Comprehensive evaluation Repeated analysis of variance
  • 相关文献

参考文献9

二级参考文献152

共引文献5368

同被引文献40

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部